Pain Relief Patch

Description

The product is identified by the SPL code 34089-3 and is formulated as a medicated patch intended for daily use. Each package contains a total of 60 patches.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints, including conditions such as arthritis, simple backache, muscle strains, muscle sprains, and bruises.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and over should begin by cleaning and drying the affected area, ensuring it is free of lotions, ointments, and creams. The patch should be removed from its protective film and applied directly to the affected area. It is important to note that no more than one patch should be used within an 8-hour period. The application may be repeated as necessary, but the total number of patches used in a single day must not exceed three. Each patch is for single use only and should be discarded after application. After opening, the pouch should be resealed to maintain the integrity of the remaining patches.

For children under 12 years of age, it is advised to consult a physician before use.

Contraindications

Use of this product is contraindicated in the following situations:

Patients with a known allergy to any ingredient in this product should not use it due to the risk of allergic reactions.

Application of more than one patch on the body simultaneously is contraindicated to prevent potential overdose or increased side effects.

The product should not be applied to wounds or damaged skin, as this may lead to increased absorption and adverse effects.

Concurrent use with a heating pad is contraindicated due to the potential for enhanced absorption and increased risk of systemic effects.

Additionally, the use of this product alongside other topical analgesics is contraindicated to avoid additive effects and potential toxicity.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to exercise caution and consult a physician prior to use if they have a known allergy to aspirin or salicylates, as this may increase the risk of an allergic reaction.

Patients should be instructed to discontinue use and seek medical advice if any of the following occur: the development of a rash, itching, or excessive skin irritation; worsening of the condition; persistence of symptoms beyond 7 days; or recurrence of symptoms after initial improvement. Monitoring for these adverse effects is essential to ensure patient safety and effective management of any potential reactions.

Side Effects

Patients should be aware that the product is intended for external use only. An allergy alert is warranted; individuals with a known sensitivity to aspirin or salicylates are advised to consult a healthcare professional prior to use.

In clinical practice, it is important to monitor for adverse reactions. Patients should discontinue use and seek medical advice if they experience rash, itching, or excessive skin irritation. Additionally, if the condition being treated worsens, symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days, medical consultation is recommended.

Drug Interactions

Concurrent use of this medication with other topical analgesics is contraindicated due to the potential for additive effects, which may increase the risk of adverse reactions. It is advised to avoid simultaneous application to ensure patient safety and efficacy of treatment.

Patients with a known allergy to aspirin or salicylates should exercise caution. It is recommended that individuals with such sensitivities consult a healthcare professional prior to using this medication to mitigate the risk of allergic reactions.

Packaging & NDC

Below are the non-prescription pack sizes of Pain Relief Patch (camphor, methyl salicylate, menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a physician prior to use. The safety and efficacy of this medication in this age group have not been established, and appropriate dosing has not been determined. Caution is advised when considering treatment for children in this age range.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the context of overdosage, it is important to note that there is no specific information available regarding the effects or management of an overdose for this medication. Healthcare professionals are advised to exercise caution and consider the potential implications of an overdose based on the pharmacological profile of the drug.

In the absence of detailed overdosage data, it is recommended that healthcare providers monitor patients closely for any unusual symptoms or adverse reactions that may arise. Supportive care should be initiated as necessary, and symptomatic treatment should be provided based on the clinical presentation of the patient.

In cases of suspected overdose, it is advisable to contact a poison control center or seek expert consultation for guidance on appropriate management strategies. Continuous assessment and monitoring of the patient's vital signs and overall condition are essential to ensure safety and effective intervention.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. Individuals with a known allergy to aspirin or salicylates should seek medical advice before using the product. In the event of rash, itching, or excessive skin irritation, it is recommended to discontinue use and consult a healthcare provider, especially if the condition worsens, persists for more than seven days, or recurs after clearing.

No relevant information regarding carcinogenicity, mutagenicity, or animal pharmacology and toxicology is available in the current data.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately at 1-800-222-1222.

Patients should be informed not to use more than one patch on their body at a time, and to avoid applying it on wounds or damaged skin. They should also refrain from using the patch in conjunction with a heating pad or if they have a known allergy to any of the product's ingredients.

It is important for healthcare providers to counsel patients to stop using the product and consult a doctor if they experience a rash, itching, or excessive skin irritation. Patients should also be advised to seek medical attention if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

When using this product, patients should be instructed to use it only as directed. They should avoid contact with the eyes, mucous membranes, or rashes, and should not bandage the area tightly. Additionally, patients should be cautioned against using this product simultaneously with other topical analgesics.

Storage and Handling

The product is supplied in a clean, dry container designed to protect its contents from excessive moisture and direct sunlight. It is essential to store the product in a location that maintains these conditions to ensure its integrity and efficacy.

Additional Clinical Information

The route of administration for the product is topical. For adults and children aged 12 years and older, the affected area should be cleaned and dried, free of lotions, ointments, and creams. The patch should be removed from its film and applied to the affected area, with a maximum of one patch used in an 8-hour period and no more than three patches per day. After a single use, the patch should be discarded, and the pouch resealed. For children under 12 years of age, consultation with a physician is advised.

Clinicians should counsel patients to keep the product out of reach of children and to seek medical help or contact a Poison Control Center immediately if swallowed. Pregnant or breastfeeding patients should consult a health professional before use. Patients are advised to discontinue use and consult a doctor if they experience rash, itching, excessive skin irritation, worsening conditions, or if symptoms persist beyond 7 days or recur shortly after resolution. It is important to avoid using more than one patch at a time, applying it to wounds or damaged skin, using it with a heating pad, or if allergic to any ingredients. Patients should use the product only as directed, avoiding contact with eyes, mucous membranes, or rashes, and should not bandage tightly or use concurrently with other topical analgesics.

Drug Information (PDF)

This file contains official product information for Pain Relief Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)